![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2017.36/MediaObjects/41375_2017_Article_BFleu201736_Fig1_HTML.jpg)
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
![The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ... The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ...](https://www.astctjournal.org/cms/attachment/4b4ceb2f-a5fa-4bb5-b3d6-9565f0ca7e4c/gr1_lrg.jpg)
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ...
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug | Journal of Medicinal Chemistry
![BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1756-8722-4-6/MediaObjects/13045_2010_Article_140_Fig3_HTML.jpg)
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text
![Structure of the BCR/ABL1 oncogene. (A) Schematic representation of the... | Download Scientific Diagram Structure of the BCR/ABL1 oncogene. (A) Schematic representation of the... | Download Scientific Diagram](https://www.researchgate.net/publication/349056196/figure/fig2/AS:987844025798663@1612531777961/Structure-of-the-BCR-ABL1-oncogene-A-Schematic-representation-of-the-t922-q34q11.png)
Structure of the BCR/ABL1 oncogene. (A) Schematic representation of the... | Download Scientific Diagram
![Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia](https://www.frontiersin.org/files/Articles/81229/fonc-04-00054-HTML/image_m/fonc-04-00054-g002.jpg)
Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
![Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/76e1ca46-30ec-49c1-b325-a7c53fedc91f/fx1_lrg.jpg)